HNST · The Honest Company, Inc.

The thesis

The Honest Company's turnaround case rests on one question: can organic growth and gross margin, excluding one-time tariff refunds, hold at second-quarter levels? The Q3 2026 report settles it. Investing.com lists that report for 11 November 2026, but the company has not confirmed the date. Until then the shares have no company-specific catalyst, and price momentum has turned down.

The test is unchanged from the prior note. Q3 needs organic growth of at least 5%, an underlying adjusted gross margin of at least 43.8% and no cut to the annual outlook. These are research thresholds drawn from the Q2 results and full-year guidance. They are not quarterly targets issued by the company.

The narrative is maturing. The 5 August guidance increase is still the only financial anchor, and the 14-day relative strength index (RSI) fell to 32.1 at the 1 October close of $5.02. On 4 September, Benzinga had flagged the same shares as overbought with an RSI above 70. The odds of beating the S&P 500 over three months are rated low. The shares trade close to the analyst targets, and the deciding report falls outside the next 30 days.

Bullish and bearish views on The Honest Company, Inc.

The bull case on The Honest Company, Inc. (HNST), in brief: Underlying margin hit a record. The bear case: Refunds inflated the headline margin.

Bull case

• Underlying margin hit a record. The Q2 release of 5 August 2026 reported underlying adjusted gross margin of 43.8%, up 340 basis points from a year earlier. That figure excludes transformation costs, tariff refunds and the remaining apparel liquidation. Q2 results
• Management raised the full-year outlook. On 5 August 2026 the company lifted FY2026 guidance to revenue of $319–325 million and organic growth of 5–7%, with adjusted gross margin in the mid-40s (percent). A Q3 result that holds this outlook would confirm the operating recovery.
• Profit is up while the share count falls. Simply Wall St reports Q2 2026 sales of $83.30 million and net income of $10.69 million, alongside a completed $25 million share repurchase program. The 10-Q cover lists 107.28 million shares outstanding as of 28 August 2026. Simply Wall St

Bear case

• Refunds inflated the headline margin. The 5 August 2026 release reported Q2 gross margin of 48.4%, including $6.6 million of tariff refunds. Only the underlying 43.8% figure says anything about the repeatable business.
• Reported revenue is still shrinking. Q2 reported revenue fell 10.9% while organic revenue grew 6.7%, according to the 5 August 2026 release. The gap reflects strategic exits under the Powering Honest Growth plan.
• Q3 consensus implies a step down. Investing.com shows a Q3 consensus of $77.25 million in revenue and $0.005 in earnings per share (EPS), as checked 2 October 2026. That is below the $83.30 million in Q2 sales. Investing.com earnings
• Analyst targets cap the upside. Stock Analysis shows an average target of $5.20. Morgan Stanley's target is $5.70 with a Hold rating (12 August 2026). Freedom Broker, B. Riley and Telsey each set $5.00 (6 August 2026). No target change since mid-August appears in that table. Stock Analysis forecast

Price setup

The shares closed at $5.02 on 1 October 2026, 15.6% below the 52-week high of $5.95. That close is down from $5.29 on 25 September 2026 in the same split- and dividend-adjusted series. The three-month gain has narrowed to 27.4%, from 44.9% on 25 September.

Crowding has unwound. RSI went from above 70 in Benzinga's 4 September 2026 screen to 32.1 on 1 October, so the late-summer momentum buying has left the shares. The 1 October close sits $0.02 above $5.00, the level where three analysts placed their August targets. Most 2026 insider sales on Form 4 are sell-to-cover transactions on vesting restricted stock units, so they say little in either direction.

Catalysts, next 30 days

• No confirmed company event before 1 November 2026. No earnings date, investor-day date or regulatory decision has been announced for the next 30 days.
• ~11 November 2026 (est.): Q3 2026 results. Investing.com lists 11 November after the market close; MarketBeat earlier estimated about 4 November. Q3 results came on 12 November 2024 and 5 November 2025. The report tests organic growth, underlying gross margin and the FY2026 guidance against the thresholds above.

What would change the view

The case breaks if Q3 organic growth comes in below 5%, if underlying adjusted gross margin falls below the Q2 mark of 43.8%, or if the company cuts its FY2026 organic-growth or adjusted-gross-margin outlook. On price, a weekly close below $5.00 would put the shares under the cluster of August analyst targets and end the turnaround reading.

The read would turn more constructive on two signs. One is a Q3 report that meets all three thresholds and raises guidance. The other is a weekly close above the $5.95 52-week high, which would show buying returning ahead of the report.

What it trades with

Honest sells diapers, wipes and personal care products. It competes with large staples makers such as Procter & Gamble and Kimberly-Clark. Its margin story is tied to tariff policy: refunds lifted Q2 reported margin, and changes in tariffs would move costs again. In the 4 September 2026 Benzinga overbought screen it was grouped with Utz Brands and Village Farms, which suggests it trades as a small-cap momentum stock as much as a staples name. Company results, not sector moves, decide this thesis.